Skip to main content

Table 1 Patient Demographics of cancer cohort at time of recruitment

From: Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours

Characteristic N (%) or median (interquartile range)
Endometrial cancer cohort Ovarian cancer cohort
Age (year) 70 (57-77) 63 (52-69)
 Histological subtype
  Endometrioid 24 (59) 3 (12)
  Serous 6 (15) 15 (58)
  Clear cell 5 (12) 1 (4)
  Squamous cell - 1 (4)
  Carcinosarcoma 4 (10) -
  Adenocarcinoma NOS - 1 (4)
  Not recorded 2 (5) 2 (8)
Grade
 Borderline - 3 (12)
 G1 14 (34) 4 (15)
 G2 10 (24) 3 (12)
 G3 17 (41) 16 (62)
FIGO stage
 I 29 (71) 8 (31)
 II 4 (10) 4 (15)
 III 7 (17) 10 (38)
 IV 1 (2) 1 (4)
 Not recorded - 3 (12)